Blood consult: paroxysmal nocturnal hemoglobinuria and its complications.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Interaction between Herpes Virus Infections and IL10 and Risk of Bone Marrow Suppression.International journal of organ transplantation medicine · 2018
   Article
2. Eculizumab in the management of paroxysmal nocturnal hemoglobinuria: patient selection and special considerations.Therapeutics and clinical risk management · 2016
   Review
3. Paroxysmal nocturnal hemoglobinuria: a complement-mediated hemolytic anemia.Hematology/oncology clinics of North America · 2015
   Review
4. Successful pregnancy outcome in paroxysmal nocturnal hemoglobinuria (PNH) following escalated eculizumab dosing to control breakthrough hemolysis.Leukemia research reports · 2015
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as